EOD Regional Nodes

Notes

**Note 1:** Code only regional nodes and nodes, NOS, in this field. Distant nodes are coded in EOD Mets. **Note 2:** When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and lymph node detail are available, record the code with lymph node detail in preference to a statement of FIGO stage. **Note 3:** Isolated tumor cells (ITCs) are defined as single tumor cells or small clusters not greater than 0.2 mm, usually detected by immunohistochemical (IHC) or molecular methods. ITCs do not usually show evidence of malignant activity (e.g., proliferation or stromal reaction). Lymph nodes with ITCs only are not counted as positive nodes. * For positive ITCs with NO regional lymph node involvement, code 050 **Note 4:** Regional lymph nodes include * Pelvic, NOS (codes 100-300) - Iliac, NOS + Common + External + Internal (hypogastric) (obturator) - Paracervical - Parametrial - Pelvic, NOS - Sacral, NOS + Lateral (laterosacral) + Middle (promontorial) (Gerota's node) + Presacral + Uterosacral * Para-aortic, NOS (WITH or WITHOUT pelvic lymph nodes) (codes 400-600) - Aortic - Lateral aortic/lateral lumbar - Periaortic **Note 5:** Code 800 if regional lymph nodes are involved, but there is no indication which ones are involved.
Code Description SS2018 N
000 No regional lymph node involvement NONE
050 Isolated tumor cells * Lymph node metastasis less than or equal to 0.2 mm NONE
100 Pelvic lymph nodes * Lymph node metastasis greater than 0.2 mm but not greater than 2.0 mm in diameter RN
200 Pelvic lymph nodes * Lymph node metastasis greater than 2.0 mm in diameter RN
300 Pelvic lymph nodes * Size of lymph node metastasis unknown FIGO Stage IIIC1 RN
400 Para-aortic lymph nodes * Lymph node metastasis greater than 0.2 mm but not greater than 2.0 mm in diameter * WITH or WITHOUT pelvic lymph nodes RN
500 Para-aortic lymph nodes * Lymph node metastasis greater than 2.0 mm in diameter * WITH or WITHOUT pelvic lymph nodes RN
600 Para-aortic lymph nodes * Size of lymph node metastasis unknown * WITH or WITHOUT pelvic lymph nodes FIGO Stage IIIC2 RN
800 Regional lymph node(s), NOS Lymph node(s), NOS RN
999 Unknown; regional lymph node(s) not stated Regional lymph node(s) cannot be assessed Not documented in medical record Death Certificate Only U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging.** In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (6) Powell, M.A., Olawaiye, A.B., Mutch, D.G., et al. **Corpus Uteri - Carcinoma and Carcinosarcoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017